Unlocking menstrual fluid as a clinically viable biospecimen
NariNext builds standardized collection and stabilization infrastructure to enable research, diagnostics, and clinical insight from menstrual fluid. By addressing pre-analytical variability at the source, we make menstrual fluid usable across scientific and clinical applications.
Our Innovation
NariNext is developing a standardized, lab-ready menstrual fluid collection and stabilization platform for research and diagnostic use. By controlling pre-analytical variability in a historically inconsistent biospecimen, we enable reproducible biomarker discovery across fertility, endometriosis, PCOS, oncology, and related disease areas. Our platform is designed for scientific and clinical workflows—not consumer wellness.
Our Mission
NariNext advances a future in which women’s biological data is held to the same scientific standard as every other major biospecimen—so research, diagnostics, and care are no longer constrained by what has historically been ignored.
Meet the Team
Experts. Innovators. Trailblazers.
Rifat Hasina, PhD
Founder & CEO
Rifat is a biomedical scientist and entrepreneur with prior startup experience, bringing over two decades of work at the intersection of research, diagnostics, and translation. Through her work in molecular diagnostics, she saw firsthand how biological samples shape what science can—and cannot—measure. NariNext grew out of that insight: to build the missing infrastructure for menstrual fluid research.
Advisors
Farzana Ali, PhD
Research & Development
Jeanette Numbers
Design and Engineering
Chelsea Eyre
Commercial Strategy
Wesley Okeke
Business Development
NariNext 